Atlantic Union Bankshares’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
SCM
PCM
NIM
FHA
RCM
Atlantic Union Bankshares's HQL Position: Q1 2026 in Review
Atlantic Union Bankshares held its abrdn Life Sciences Investors (HQL) position steady in Q1 2026 at 17,808 shares worth $290K. The position accounts for 0.01% of the portfolio, ranked #528.
Atlantic Union Bankshares first reported a position in HQL in Q2 2019 and has held it in 28 quarters since. The position peaked at $2.2M in Q2 2021. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.
- Atlantic Union Bankshares held 17,808 shares of abrdn Life Sciences Investors worth $290K as of Q1 2026.
- Atlantic Union Bankshares left its abrdn Life Sciences Investors share count unchanged in Q1 2026.
- abrdn Life Sciences Investors made up 0.01% of Atlantic Union Bankshares's portfolio in Q1 2026, its #528 holding.
- Atlantic Union Bankshares first reported a position in abrdn Life Sciences Investors in Q2 2019 and has held it in 28 quarters since.
- Atlantic Union Bankshares's abrdn Life Sciences Investors position peaked at $2.2M in Q2 2021.
- 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.
Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.